Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
3.19Price to Book
VS
Market
Sector
Industry
History
$ 4.72Close
$ 1.13 - $ 5.34 52-Week Range
Ticker Information
Ticker
TSHACompany Name
TAYSHA GENE THERAPIES INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQTAYSHA GENE THERAPIES INC - Price to Book Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
TSHA - P/B Historical data
| Date | Shareholders Equity | Market Capitalization | Price to Book |
|---|---|---|---|
| 6/30/2025 | $ 248.73M | $ 793.83M | 3.19 |
| 3/31/2025 | $ 55.06M | $ 549.53M | 9.98 |
| 12/31/2024 | $ 71.53M | $ 332.1M | 4.64 |
| 9/30/2024 | $ 88.8M | $ 452.92M | 5.1 |
| 6/30/2024 | $ 108.87M | $ 418.08M | 3.84 |
| 3/31/2024 | $ 53.85M | $ 480.64M | 8.93 |
| 12/31/2023 | $ 74.94M | $ 420.79M | 5.62 |
| 9/30/2023 | $ -49.11M | $ 248.66M | 0 |
| 6/30/2023 | $ -37.11M | $ 137.31M | 0 |
| 3/31/2023 | $ -14.95M | $ 45.5M | 0 |
Key Performance Insights, Last 5 Years
- TAYSHA GENE THERAPIES INC's latest trailing twelve months (TTM) P/B stands at 2.84.
- Over the past 5 years, TAYSHA GENE THERAPIES INC's average P/B has been 7.37.
- The median P/B for TAYSHA GENE THERAPIES INC during this period was 4.31
- TAYSHA GENE THERAPIES INC reached its highest P/B over the past 5 years at 43.61.
- The lowest P/B recorded by TAYSHA GENE THERAPIES INC in the same timeframe 2.63
TAYSHA GENE THERAPIES INC's P/B vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/B Benchmarks
Similar metrics to P/B:
- Price to Sales - [Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
Definition of Price to Book
[Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].Market Cap / Equity
(=) P/B P/B for TAYSHA GENE THERAPIES INC is calculated as follows: Market Cap [ $ 759M ] / Equity [ $ 267.64M ]
(=) P/B [ 2.84 ] TSHA - Price to Book, Last 5 years
2.63
Minimum
Dec 31, 2021
43.61
Maximum
Dec 31, 2022
7.37
Average
4.31
Median
P/B Benchmark AnalysisMarket
The chart above depicts the distribution of P/B for companies in the Total Stock Market. The average P/B of the companies is 2.29 with a standard deviation of 1.81.
The following table provides additional summary stats:
P/B in the Market:
| filtered constituents | 3.36K |
|---|---|
| min | 0 |
| max | 8.04 |
| average | 2.29 |
| median | 1.63 |
| std | 1.81 |